
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

Japanese pharmaceutical company Shionogi and US-based Maze Therapeutics have finalised an exclusive worldwide license agreement for MZE001, a novel therapeutic …

French pharma and healthcare company Sanofi and US biotech Novavex, have entered into a co-exclusive licensing agreement for a number …

Amneal Pharmaceuticals has announced that it has entered into an exclusive licensing agreement with Zambon Biotech for IPX204 in the …

Pharmanovia and Stealth BioTherapeutics have announced that they have entered into a new licensing agreement for the marketing and further …